KOS PHARMACEUTICALS INC·4

May 16, 5:55 PM ET

BALDINI ROBERT E 4

4 · KOS PHARMACEUTICALS INC · Filed May 16, 2005

Insider Transaction Report

Form 4
Period: 2005-05-12
Transactions
  • Sale

    Common Stock, $.01 Par Value

    2005-05-12$53.38/sh20,000$1,067,6006,524 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2005-05-1220,0000 total
    Exercise: $19.88Exp: 2010-10-16Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock, $.01 Par Value

    2005-05-12$19.88/sh+20,000$397,60026,524 total
Footnotes (3)
  • [F1]One share owned jointly with spouse.
  • [F2]Includes 6,523 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) Plan and the Employee Stock Purchase Plan.
  • [F3]Part of an original grant of 50,000 options, exercisable in the following amounts on the following exercise dates: 12,500 on October 17, 2001 12,500 on October 17, 2002 12,500 on October 17, 2003 12,500 on October 17, 2004

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT